Elliot Marseille

Elliot Marseille, founding director of UC Berkeley’s Collaborative for the Economics of Psychedelics, discusses the economics behind emerging psychedelic therapies. Topics include the societal cost of not making psychedelic therapy accessible, his work with the SABA Foundation studying HIV/AIDS treatments, issues with recent ICER report on MDMA-assisted psychotherapy, and the need for long-term studies tracking healthcare utilization post-therapy.

Dr. Elliot Marseille, UC Berkeley Healthcare Economist, discusses the economic and financial aspects of psychedelic therapies. They explore the cost, insurance coverage, and value of a psychedelic experience. They also highlight the cost-effectiveness of MDMA therapy for PTSD and the potential future availability and affordability of psychedelic therapies.